These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group. Scudder SA; Liu PY; Wilczynski SP; Smith HO; Jiang C; Hallum AV; Smith GB; Hannigan EV; Markman M; Alberts DS; Gynecol Oncol; 2005 Mar; 96(3):610-5. PubMed ID: 15721401 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of paclitaxel and carboplatin in patients with endometrial cancer]. Nakamura T; Onishi Y; Yamamoto F; Kouno S; Maeda Y; Hatae M Gan To Kagaku Ryoho; 2000 Feb; 27(2):257-62. PubMed ID: 10700897 [TBL] [Abstract][Full Text] [Related]
8. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601 [TBL] [Abstract][Full Text] [Related]
9. Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer. Akram T; Maseelall P; Fanning J Am J Obstet Gynecol; 2005 May; 192(5):1365-7. PubMed ID: 15902110 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study. Tsavaris N; Kosmas C; Skopelitis H; Dimitrakopoulos A; Kopterides P; Bougas D; Stravodimos K; Mitropoulos D; Alamanis C; Giannopoulos A J Chemother; 2005 Aug; 17(4):441-8. PubMed ID: 16167525 [TBL] [Abstract][Full Text] [Related]
12. Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen. Kouno T; Ando M; Yonemori K; Matsumoto K; Shimizu C; Katsumata N; Komiyama M; Okajima E; Matsuoka N; Fujimoto H; Fujiwara Y Eur Urol; 2007 Oct; 52(4):1115-22. PubMed ID: 17433855 [TBL] [Abstract][Full Text] [Related]
13. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group. Bamias A; Papadimitriou C; Efstathiou E; Rodolakis A; Vlahos G; Voulgaris Z; Bozas G; Fountzilas G; Aravantinos G; Razis E; Gika D; Dimopoulos MA BMC Cancer; 2006 Sep; 6():228. PubMed ID: 16999858 [TBL] [Abstract][Full Text] [Related]
14. A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group. Pignata S; Scambia G; Pisano C; Breda E; Di Maio M; Greggi S; Ferrandina G; Lorusso D; Zagonel V; Febbraro A; Riva N; De Rosa V; Gallo C; Perrone F; Br J Cancer; 2007 Jun; 96(11):1639-43. PubMed ID: 17486128 [TBL] [Abstract][Full Text] [Related]
15. Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study. Vaishampayan UN; Faulkner JR; Small EJ; Redman BG; Keiser WL; Petrylak DP; Crawford ED Cancer; 2005 Oct; 104(8):1627-32. PubMed ID: 16138364 [TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution. Pectasides D; Pectasides E; Papaxoinis G; Xiros N; Sykiotis C; Papachristodoulou A; Tountas N; Panayiotides J; Economopoulos T Gynecol Oncol; 2008 Sep; 110(3):299-303. PubMed ID: 18602677 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck. Wang TF; Chu SC; Kao RH; Yao CY; Li CC Jpn J Clin Oncol; 2008 Jul; 38(7):459-63. PubMed ID: 18586668 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer. Johannsen M; Sachs M; Roigas J; Hinke A; Staack A; Loening SA; Schnorr D; Wille AH Eur Urol; 2005 Aug; 48(2):246-51. PubMed ID: 15963636 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma. Hidaka T; Nakamura T; Shima T; Yuki H; Saito S J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer. Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]